Clinical Trials Directory

Trials / Unknown

UnknownNCT00778076

The Impact of Hyaluronic Acid Injections on Osteoarthritic Knee Mechanics

The Biomechanical Impact of Intra-Articular Hyaluronic Acid in Knee Osteoarthritis Patients: A Randomized, Double Blind, Placebo Controlled Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Western Ontario, Canada · Academic / Other
Sex
All
Age
60 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the impact of a regular course of treatment with Hyaluronic acid (HA) injections on gait in knee osteoarthritis (OA) patients. Three consecutive HA injections will be compared to three consecutive placebo injections to determine whether HA's analgesic effect is greater than that of a placebo injection, and to observe whether HA's viscoelastic properties are manifested in a human knee OA population. We hypothesize that HA injections will relieve pain to a greater extent than placebo injections in knee OA patients, and will afford them with improved walking characteristics, such as increased walking speed, and step length.

Detailed description

Knee osteoarthritis (OA) is a severely debilitating disease associated with stiffness and pain in the knee joint, and with a loss of function. Hyaluronic acid (HA) injections are incorporated into non-surgical standard of care for knee OA patients and have been proven to relieve pain in patients who have not received symptomatic relief with other knee OA interventions. HA allows synovial fluid to act as a lubricant and shock absorber for joints, and although this is encouraging ground to advocate for the use of HA treatment in knee OA patients, these properties have yet to be proven in a controlled clinical trial setting. Therefore, we are undertaking this study to observe whether the physiological adaptation in the OA knee joint, initiated by HA injection, will result in biomechanical improvements in human knee OA patients, specifically walking mechanics.

Conditions

Interventions

TypeNameDescription
DEVICEHyaluronic acid3 consecutive injections, each one week apart, of 20mg/2ml Hyaluronic acid.
DEVICEPlacebo (Saline injection)3 consecutive injections, each one week apart, of 20mg/2ml of Placebo.

Timeline

Start date
2008-07-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2008-10-23
Last updated
2009-04-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00778076. Inclusion in this directory is not an endorsement.